We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
Documents, certificate, letters, and notes available from the British embassy and consulates in the USA.
Deputy Ambassador Deirdre Brown commends the work of the OSCE Mission, particularly during a critical year for Moldova.
Joint readout by the Minister of Foreign Affairs of Mongolia and the UK Foreign Secretary.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
Invitation to comment launched by the CMA on the partnerships between Microsoft and Mistral AI, and Amazon and Anthropic, and Microsoft’s hiring of former employees and related arrangements with Inflection AI.
Minister for Crime, Policing and Fire promotes the UK’s balanced approach towards tackling drug use, with a focus on the challenge of synthetic opioids.
Check the tariff classification for peptide nisin standardised with sodium chloride
Details of General Licences issued by OFSI
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
Fresenius Kabi Limited has informed the MHRA of an error on the infusion bag packaged into the specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex.
Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA.
Advice and guidance on the health needs of migrant patients from Bolivia for healthcare practitioners.
Employment Appeal Tribunal Judgment of Judge Shanks on 16 April 2024.
Employment Appeal Tribunal Judgment of Lord Fairley on 18 April 2024.
Check the tariff classification for oilcake and other residues resulting from the extraction of olive oil.
Keep up to date with the UK policy development in respect of Standard Essential Patents.
A. Menarini Farmaceutica Internazionale Srl is recalling a specific batch as a precautionary measure due to the distribution of Invokana 300mg in Northern Ireland in packaging intended for the Greek market.
Information on how UK companies can control risks when doing business in Mexico.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.